Target intelligence / Profile preview

Penicillin-binding protein 1b and 3 (PBP-1b and PBP-3)

Target
PBP-1b and PBP-3
Molecular classification
Enzyme, Transpeptidase, Transglycosylase, DD-transpeptidase
01

Overview

Penicillin-binding proteins (PBPs) are essential bacterial enzymes located in the periplasmic space that catalyze the final stages of peptidoglycan biosynthesis, the primary component of the bacterial cell wall [6, 10]. PBP-1b is a bifunctional Class A enzyme with both transglycosylase and transpeptidase activities, primarily responsible for cell wall elongation and maintaining structural integrity [1, 3, 16]. PBP-3, a Class B monofunctional transpeptidase, is critical for septum formation during bacterial cell division [7, 10, 19]. These proteins are the primary targets of beta-lactam antibiotics, including penicillins, cephalosporins, carbapenems, and monobactams [13, 15]. Drugs bind covalently to the active-site serine of PBPs, inhibiting the cross-linking of peptidoglycan strands, which leads to cell wall weakening, filamentation (specifically with PBP-3 inhibition), and eventual osmotic lysis and cell death [7, 10, 13]. Resistance often arises through the production of beta-lactamases or mutations in the PBP genes that reduce drug affinity [17]. Understanding the specific affinities of antibiotics for different PBPs is crucial for predicting their bactericidal efficacy and morphological effects on bacteria [14].

Other names
MrcBPonAFtsISeptum peptidoglycan synthetaseBifunctional transglycosylase/transpeptidase PBP1bDD-transpeptidase
02

Mechanism of action

Inhibition of peptidoglycan transpeptidation by covalent binding to the active-site serine, preventing cell wall cross-linking and leading to bacterial lysis.

03

Biological functions

Peptidoglycan biosynthesisCell wall assemblyCell elongationCell divisionSeptation
04

Disease associations

Infection
05

Safety considerations

Antimicrobial resistanceBeta-lactam hypersensitivityAnaphylaxisGastrointestinal dysbiosisClostridioides difficile infection
06

Interacting drugs

Ampicillin

9 more in the full profile.

07

Biomarkers

Minimum inhibitory concentration (MIC)BOCILLIN FL binding affinityftsI gene mutationsmrcB gene mutationsponA gene mutations

Beyond the preview

Go deeper on Penicillin-binding protein 1b and 3 (PBP-1b and PBP-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Penicillin-binding protein 1b and 3 (PBP-1b and PBP-3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call